Clade Therapeutics - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Clade Therapeutics M&A Summary

Clade Therapeutics has acquired 1 company of its own, including 1 in the last 5 years.

The Company’s most targeted sectors include life science (100%).

Clade Therapeutics Ownership

Who owns Clade Therapeutics?

Clade Therapeutics is owned by Century Therapeutics. It was acquired on April 11, 2024.

Clade Therapeutics Business Overview

Where is Clade Therapeutics headquartered?

Clade Therapeutics is headquartered in Boston, Massachusetts.

What sector is Clade Therapeutics in?

Clade Therapeutics is a life science company.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

Clade Therapeutics

Clade Therapeutics, Inc.

201 Brookline Avenue, Suite 1002,
Boston, Massachusetts 02215
United States,
(617) 546-7460
www.cladetx.com

Clade Therapeutics is a biopharmaceutical company focused on discovering and delivering engineerable, off-the-shelf, scalable, and consistent stem cell-based medicines. The company provides a robust cellular platform with stem-cell-derived immune cells for the treatment of cancer and autoimmune diseases. Clade Therapeutics is based in Boston, Massachusetts.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # - - - - 1 - 1
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Gadeta B.V. 2023-10-02 - Add-on Acquisition
Utrecht, Netherlands · www.gadeta.nl
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) - - -
Total 1 - - -

By Geo

State/Country Buy Value Sell Value
Netherlands 1 - - -
Total 1 - - -

 Subscribe to unlock this and 209,180
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.